US FDA approves Amylin's diabetes drug

www.reuters.com: : WASHINGTON (Reuters) - Amylin Pharmaceuticals won U.S. approval on Friday for its Bydureon diabetes drug, a long-awaited victory for the company's most promising product.After two delays, the Food and



9 people shared this link in the last 24 hours.

Related Articles

  • FDA approves controversial diet drug - CBS News Video

    www.cbsnews.com
    Shared once

    CBS News video: FDA approves controversial diet drug - FDA medical experts are recommending approval of the diet pill Qnexa, despite the drug's potential risky side effects. Dr. Jon LaPook reports.

  • FDA acts to stem shortages of two cancer drugs

    www.reuters.com
    Shared 11 times

    (Reuters) - The Food and Drug Administration is addressing the U.S. shortage of critical cancer medications by importing one drug from abroad and rushing the approval of another.The move announced on

  • FDA staff oppose Northera hypotension drug

    www.reuters.com
    Shared 4 times

    WASHINGTON (Reuters) - Health regulators recommended that Chelsea Therapeutics International Ltd's hypotension drug Northera not be approved for use in the United States, sending the company's shares down

  • FDA acts to stem shortages of two cancer drugs

    health.yahoo.net
    Shared once

    (Reuters) - The Food and Drug Administration is addressing the shortage of critical cancer medications by importing one drug from abroad and rushing the approval of another.

  • US health experts give nod to new obesity drug - Yahoo! News

    news.yahoo.com
    Shared 2 times

    From Yahoo! News: An advisory panel to the US Food and Drug Administration on Wednesday urged approval of a new obesity drug, Qnexa, after warning against its approval in 2010 due to safety concerns.

Top Links

blog comments powered by Disqus